MYC and lung carcinoma: The positive loop between FACT and c‐MYC can be considered as a therapeutic target in preventing recurrence of lung cancer, since, despite the significant progress in primary treatment of lung cancer, recurrence still occurs after the molecular targeted treatment and immunotherapy.27, 28